Senior insider sale
Chief Commercial Officer at TRAVERE THERAPEUTICS, INC. — senior position signals high conviction
$6.72M
102.19K shares
What this filing means
HEERMA PETER plans to sell 102.19K shares of TRAVERE THERAPEUTICS, INC. valued at approximately $6.72M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/15/2026ACC: 0001950047-26-009510
Officer· Chief Commercial Officer
Since Oct 2019
102.19K
Shares to sell
$6.72M
Approx. market value
102.19K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months3
Exercise of Stock Options
Cash
9/15/2026
77.19KPerformance Stock Units
N/A
2/10/2025
5.43KRestricted Stock Units
N/A
10/1/2021
19.57KTotal acquired102.19K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/15/2026 | Exercise of Stock Options Cash | 77.19K | — |
2/10/2025 | Performance Stock Units N/A | 5.43K | — |
10/1/2021 | Restricted Stock Units N/A | 19.57K | — |
| Total | 102.19K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
102.19K
Market value
$6.72M
9/15/2026
Total
Units
102.19K
Value
$6.72M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
9/15/2026 | 102.19K | $6.72M | NASDAQ | Planned |
| Total | 102.19K | $6.72M | ||